|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0006675,
umls-concept:C0022885,
umls-concept:C0025267,
umls-concept:C0030705,
umls-concept:C0039082,
umls-concept:C0039593,
umls-concept:C0043515,
umls-concept:C0221002,
umls-concept:C0442027,
umls-concept:C0596473,
umls-concept:C1704410
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
1997-1-10
|
|
pubmed:abstractText |
In patients with the Zollinger-Ellison syndrome, the exclusion of multiple endocrine neoplasia type 1 is of important clinical relevance. Its diagnosis often relies on the existence of primary hyperparathyroidism.
|
|
pubmed:commentsCorrections |
http://linkedlifedata.com/resource/pubmed/commentcorrection/8977343-1352963,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8977343-1455312,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8977343-1677253,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8977343-197123,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8977343-2573955,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8977343-2573957,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8977343-2686566,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8977343-2891201,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8977343-3048457,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8977343-3599657,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8977343-3608153,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8977343-5639642,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8977343-6248272,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8977343-6493158,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8977343-7903006,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8977343-7977432,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8977343-8097874
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Aug
|
|
pubmed:issn |
0017-5749
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
39
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
273-8
|
|
pubmed:dateRevised |
2009-11-18
|
|
pubmed:meshHeading |
pubmed-meshheading:8977343-Administration, Oral,
pubmed-meshheading:8977343-Adult,
pubmed-meshheading:8977343-Aged,
pubmed-meshheading:8977343-Calcium,
pubmed-meshheading:8977343-Female,
pubmed-meshheading:8977343-Humans,
pubmed-meshheading:8977343-Hyperparathyroidism,
pubmed-meshheading:8977343-Male,
pubmed-meshheading:8977343-Middle Aged,
pubmed-meshheading:8977343-Multiple Endocrine Neoplasia Type 1,
pubmed-meshheading:8977343-Parathyroid Hormone,
pubmed-meshheading:8977343-Prospective Studies,
pubmed-meshheading:8977343-Zollinger-Ellison Syndrome
|
|
pubmed:year |
1996
|
|
pubmed:articleTitle |
Oral calcium tolerance test in the early diagnosis of primary hyperparathyroidism and multiple endocrine neoplasia type 1 in patients with the Zollinger-Ellison syndrome. Groupe de Recherche et d'Etude du Syndrome de Zollinger-Ellison.
|
|
pubmed:affiliation |
Service de Gastroentérologie, Hopital Bichat-Claude Bernard, Paris, France.
|
|
pubmed:publicationType |
Journal Article
|
